News

New Alzheimer’s drug could slow down cognitive decline

A new Alzheimer’s drug, which has been labeled “historic” by some experts, could slow the progression of cognitive decline by 27% compared with a placebo. 

The monoclonal antibody treatment called lecanemab was developed by drugmakers Biogen and Eisai and was recently tested in a Phase 3 global clinical trial. 

The results of the study show that the drug reduced amyloid levels – a protein that builds up in the brian’s of Alzheimer’s patients. It also had positive effects on cognitive abilities and the patient’s ability to perform everyday tasks. 

Eisai CEO Haruo Naito said in a statement: “We believe that helping to alleviate these burdens will positively impact society as a whole. Additionally, the lecanemab Clarity AD study results prove the amyloid hypothesis, in which the abnormal accumulation of Aβ in the brain is one of the main causes of Alzheimer’s disease.”

In this trial, 1,795 volunteers in the early stages of Alzheimer’s disease were injected with lecanemab every two weeks and regularly had their memory and mental agility tested.

Although the full details haven’t been published yet, the pharmaceutical companies said that the trial results show that the pace of cognitive decline was reduced by  27% over the course of the 18 months, compared with people given a placebo. In addition to this, levels of the toxic protein were lowered in the brain over the course of the study. 

Some of the reported side effects were brain swelling and headaches. The scientists also noted that the drug doesn’t work on other types of dementia. 

Biogen chief executive Michel Vounatsos said: “Today’s announcement gives patients and their families hope that lecanemab, if approved, can potentially slow the progression of Alzheimer’s disease and provide a clinically meaningful impact on cognition and function.”

The companies are now in the process of applying for regulatory approval for the drug to be approved for use in the US, Europe, and Japan.

Linda Conrad

Recent Posts

CVS Removes Prescription Requirement for COVID-19 Vaccines Nationwide

  The US Centers for Disease Control and Prevention approved a recommendation requiring patients to…

2 weeks ago

Albanian Judge Fatally Shot Inside Tirana Courtroom

  A judge presiding at Tirana's appeals court was fatally shot Monday by a defendant…

3 weeks ago

CDC Acting Director Proposes Splitting MMR Vaccine Without Scientific Backing

  The acting director of the US Centers for Disease Control and Prevention has called…

3 weeks ago

Russia Launches Deadly Mass Strike on Ukrainian Cities

  Russia executed a large-scale overnight assault on Ukraine involving missiles and drones, resulting in…

3 weeks ago

Meta to Leverage AI Chat Data for Targeted Advertising

  Meta announced Wednesday that conversations users have with its AI chatbot will soon inform…

3 weeks ago

Taylor Swift’s Concert Film Revitalizes Theater Industry

  American cinema chains are experiencing renewed energy following another disappointing summer box office season.…

3 weeks ago